Luminous BioSciences

What Luminous BioSciences does

Luminous BioSciences is a privately held, for-profit biotechnology research products and services provider founded in 2014 and headquartered in Gaithersburg, Maryland. According to its firmographic profile, the company supplies molecular biology and cell biology research offerings, including DNA/RNA isolation, cloning, and cell culture services, addressing academic, biotech, and pharmaceutical customers who require these foundational bench capabilities. The firm operates with a reported 251-500 employee headcount and markets itself under the tagline "Your Requirements, Our Team, One Vision," which signals a customized-services orientation rather than a standardized catalog model.

Operationally, the company's business model is built around delivering research products and contract-style services in molecular and cellular biology, but the available source material does not disclose specific product SKUs, service tiering, pricing models, customer segments, go-to-market channels, or revenue mechanics. No certifications, regulatory registrations, patents, trademarks, awards, partnerships, distribution arrangements, or geographic footprint beyond the Gaithersburg headquarters are documented in the data provided. Public-facing information from the company website is limited to the firm name and tagline.

Strategically, the company sits within two structurally attractive end markets: the global plasmid DNA manufacturing market, projected to grow from USD 2.68 billion in 2025 to USD 18.11 billion by 2034 at a 21.05% CAGR, and the global gene vector market, expanding from USD 7.88 billion in 2024 to USD 42.61 billion by 2033 at a 20.92% CAGR. Despite these favorable demand tailwinds, no company-specific funding rounds, acquisitions, product launches, leadership changes, or expansion moves are evidenced in the source data, so investor-relevant strategic activity beyond the 2014 founding cannot be verified from the materials at hand.

Name

Luminous BioSciences

Website

https://luminousbio.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

251–500 employees

Short description

Luminous BioSciences is a privately held biotechnology research products and services provider founded in 2014 in Gaithersburg, Maryland, offering DNA/RNA isolation, cloning, and cell culture services to biotech, pharmaceutical, and academic customers.

Ownership category

akta.pro rank

Product category

Biotechnology Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC)

Keywords

• DNA isolation services
• RNA extraction products
• Molecular cloning services
• Cell culture services
• Biotechnology research

Headquarters

HQ city

Gaithersburg

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations

Core offering

Luminous BioSciences provides biotechnology research products and services, including DNA/RNA isolation, cloning, and cell culture services. The company positions itself around a customized partnership model under the tagline 'Your Requirements, Our Team, One Vision.' Specific named offerings are not documented on the company website.

Product overview

Based on the available source data, only a minimal website presence is documented for Luminous BioSciences. The source material consists of the company's tagline 'Your Requirements, Our Team, One Vision' and the company website URL (https://luminousbio.com/). No specific products, services, modules, or named offerings are identified in the provided source data. The product portfolio and service offerings cannot be determined from the current information.

Differentiator

Problem solved

Functional benefit

Products and services

• DNA/RNA Isolation Services

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves2 records

Expansion highlights3 records

Direct peers

• LakePharma (Curia): Biologics CDMO offering cell-line development, biologics manufacturing, and molecular biology services including DNA and cell culture work. Comparable specialty CDMO in the same services categories.
• GenScript: Global biotech services provider offering gene synthesis, cloning, DNA/RNA services, and cell-line engineering. Overlaps directly with Luminous BioSciences' DNA/RNA isolation, cloning, and cell culture offerings.
• Synthego: RNA-focused biotech supplying synthetic RNA, CRISPR reagents, and cell-engineering services. Comparable as a nucleic-acid-specialized services company serving cell and gene therapy developers.
• Twist Bioscience: Synthetic DNA and antibody engineering provider with capabilities in DNA synthesis, cloning, and synthetic biology services. Comparable as a nucleic acid-centric services and tools provider to researchers and biotech developers.
• Aldevron: Specialty manufacturer of plasmid DNA, mRNA, and proteins serving gene therapy and cell therapy developers. Directly comparable to Luminous BioSciences in nucleic acid manufacturing focus and biotech sponsor customer base.
• Eurofins Genomics: Provider of genomic services including DNA/RNA extraction, sequencing, cloning, and synthetic biology offerings. Closely aligned with the DNA/RNA isolation and cloning services described for Luminous BioSciences.

Broad incumbents

• Lonza Group: Leading global CDMO with mammalian cell-culture, microbial, and cell/gene therapy manufacturing. Competes in the same end-markets with broader scale and capability depth than Luminous BioSciences.
• Catalent: Major global CDMO providing biologics, cell and gene therapy, and nucleic acid manufacturing services at scale. Overlaps in DNA/RNA and cell culture services as part of a much broader portfolio.
• Charles River Laboratories: Large preclinical and CDMO services provider offering cell and gene therapy manufacturing, biologics, and discovery services. Broad incumbent in the same end-markets that Luminous BioSciences addresses with a narrower specialty focus.

Emerging players

• Codex DNA (Telesis Bio): Synthetic biology company offering automated DNA and mRNA synthesis and biofoundry services. Compares on DNA/mRNA production technology and services business model adjacent to Luminous BioSciences' nucleic acid work.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Luminous BioSciences